APA

Grimm W. A., Messer J. S., Murphy S. F., Nero T., Lodolce J. P., Weber C. R., Logsdon M. F., Bartulis S., Sylvester B. E., Springer A., Dougherty U., Niewold T. B., Kupfer S. S., Ellis N., Huo D., Bissonnette M. & Boone D. L. (20160628). The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon. : Gut.

Chicago

Grimm Wesley A, Messer Jeannette S, Murphy Stephen F, Nero Thomas, Lodolce James P, Weber Christopher R, Logsdon Mark F, Bartulis Sarah, Sylvester Brooke E, Springer Amanda, Dougherty Urszula, Niewold Timothy B, Kupfer Sonia S, Ellis Nathan, Huo Dezheng, Bissonnette Marc and Boone David L. 20160628. The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon. : Gut.

Harvard

Grimm W. A., Messer J. S., Murphy S. F., Nero T., Lodolce J. P., Weber C. R., Logsdon M. F., Bartulis S., Sylvester B. E., Springer A., Dougherty U., Niewold T. B., Kupfer S. S., Ellis N., Huo D., Bissonnette M. and Boone D. L. (20160628). The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon. : Gut.

MLA

Grimm Wesley A, Messer Jeannette S, Murphy Stephen F, Nero Thomas, Lodolce James P, Weber Christopher R, Logsdon Mark F, Bartulis Sarah, Sylvester Brooke E, Springer Amanda, Dougherty Urszula, Niewold Timothy B, Kupfer Sonia S, Ellis Nathan, Huo Dezheng, Bissonnette Marc and Boone David L. The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon. : Gut. 20160628.